- AutorIn
- Marie-Luise Zielmann Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany
- Manja JolinkInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany
- Christiane WinklerInstitute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany#German Center for Diabetes Research (DZD), Munich, Germany#Technical University Munich, School of Medicine, Forschergruppe Diabetes at Klinikum rechts der Isar, Munich, Germany#Forschergruppe Diabetes e.V. at Helmholtz Zentrum München, Munich, Germany
- Anne Eugster
- Denise Müller
- Marlon Scholz
- Anette-G. Ziegler
- Ezio Bonifacio
- Titel
- Autoantibodies against ATP4A are a feature of the abundant autoimmunity that develops in first-degree relatives of patients with type 1 diabetes
- Zitierfähige Url:
- https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa2-919725
- Quellenangabe
- Pediatric diabetes
Erscheinungsjahr: 2022
Jahrgang: 23
Seiten: 714-720
E-ISSN: 1399-5448 - Abstract (EN)
- Objective: Type 1 diabetes is associated with autoantibodies to different organs that include the gut. The objective of the study was to determine the risk of developing gastric parietal cell autoimmunity in relation to other autoimmunity in individuals with a family history of type 1 diabetes. Methods: Autoantibodies to the parietal cell autoantigen, H+/K+ ATPase subunit A (ATP4A) was measured in 2218 first-degree relatives of patients with type 1 diabetes, who were prospectively followed from birth for a median of 14.5 years. All were also tested regularly for the development of islet autoantibodies, transglutaminase autoantibodies, and thyroid peroxidase autoantibodies. Results: The cumulative risk to develop ATP4A autoantibodies was 8.1% (95% CI, 6.6–9.6) by age 20 years with a maximum incidence observed at age 2 years. Risk was increased in females (HR, 1.9; 95% CI, 1.3–2.8; p = 0.0004), relatives with the HLA DR4-DQ8/DR4-DQ8 genotype (HR, 3.4; 95% CI, 1.9–5.9; p < 0.0001) and in participants who also had thyroid peroxidase autoantibodies (HR, 3.7; 95% CI, 2.5– 5.5; p < 0.0001). Risk for at least one of ATP4A-, islet-, transglutaminase-, or thyroid peroxidase-autoantibodies was 24.7% (95% CI, 22.6–26.7) by age 20 years and was 47.3% (95% CI, 41.3–53.3) in relatives who had an HLA DR3/DR4-DQ8, DR4-DQ8/ DR4-DQ8, or DR3/DR3 genotype (p < 0.0001 vs. other genotypes). Conclusions: Relatives of patients with type 1 diabetes who have risk genotypes are at very high risk for the development of autoimmunity against gastric and other organs.
- Andere Ausgabe
- Link zum Artikel der zuerst in der Zeitschrift „Pediatric diabetes” erschienen ist.
DOI: 10.1111/pedi.13361 - Freie Schlagwörter (DE)
- Autoimmunität, H+/K+ ATPase, Parietalzellen-Autoantikörper, Typ-1-Diabetes, Insel-Autoantikörper
- Freie Schlagwörter (EN)
- autoimmunity, H+/K+ ATPase, parietal cell autoantibodies, type 1 diabetes, islet autoantibodies
- Klassifikation (DDC)
- 610
- Verlag
- Hindawi, London
- Förder- / Projektangaben
- Bundesministerium für Bildung und Forschung (BMBF)
- Version / Begutachtungsstatus
- publizierte Version / Verlagsversion
- URN Qucosa
- urn:nbn:de:bsz:14-qucosa2-919725
- Veröffentlichungsdatum Qucosa
- 11.06.2024
- Dokumenttyp
- Artikel
- Sprache des Dokumentes
- Englisch
- Lizenz / Rechtehinweis
CC BY 4.0